Personalized Medicine Using Cutting Edge Technologies for Genetic Epilepsies

Epilepsy is the most common chronic neurologic disorder in the world, affecting 1-2% of the population. Besides, 30% of epilepsy patients are drug-resistant. Genomic mutations seem to play a key role in its etiology and knowledge of strong effect mutations in protein structures might improve predict...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia-Rosa, Sheila, de Freitas Brenha, Bianca, Felipe da Rocha, Vinicius, Goulart, Ernesto, Araujo, Bruno Henrique Silva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686309/
https://www.ncbi.nlm.nih.gov/pubmed/32933463
http://dx.doi.org/10.2174/1570159X18666200915151909

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686309/
https://www.ncbi.nlm.nih.gov/pubmed/32933463
http://dx.doi.org/10.2174/1570159X18666200915151909

Ejemplares similares